Retour sur lavenir.net
   CMB.TECH 15.480 € (-1,02 %)     VASTNED 27.600 € (-0,36 %)     COLRUYT 36.460 € (+0,11 %)     TESSENDERLO 18.040 € (+0,89 %)     LOTUS BAKERIES 13 180.000 € (+1,38 %)     UMICORE 18.580 € (-4,47 %)     GIMV 47.350 € (0,00 %)     ABO GROUP 3.000 € (-2,60 %)     ARGENX SE 780.200 € (+6,91 %)     CIE BOIS SAUVAGE 270.000 € (-1,10 %)     WERELDHAVE BELGIUM 50.000 € (0,00 %)     BARCO 6.170 € (-14,72 %)     TUBIZE-FIN 185.000 € (+6,32 %)     SIPEF 110.800 € (+0,54 %)     EVS 18.940 € (-0,94 %)     AGEAS 74.050 € (+0,89 %)     XIOR 23.850 € (+1,06 %)     ENERGYVISION 17.680 € (-1,34 %)     ORANGE BELGIUM 22.200 € (0,00 %)     DEME GROUP 165.600 € (0,00 %)     BREDERODE 96.800 € (-0,51 %)     D'IETEREN GROUP 175.000 € (+0,81 %)     RECTICEL 11.080 € (-10,79 %)     NEXTENSA 45.500 € (+1,56 %)     AGFA-GEVAERT 0.409 € (-0,85 %)     FAGRON 23.550 € (+1,29 %)     ACKERMANS V.HAAREN 261.400 € (+0,08 %)     HOME INVEST BE. 17.940 € (+0,79 %)     AZELIS GROUP 13.020 € (-2,11 %)     TITAN S.A. 47.200 € (+0,17 %)     IMMOBEL 18.000 € (0,00 %)     KBC 115.050 € (-1,71 %)     SHURGARD 23.700 € (+1,28 %)     TINC 10.320 € (-0,58 %)     SYENSQO 78.800 € (-2,11 %)     VAN DE VELDE 29.400 € (+0,34 %)     IBA 16.180 € (-1,94 %)     WDP 19.230 € (+0,94 %)     KBC ANCORA 93.600 € (-0,53 %)     CARE PROPERTY INV. 12.180 € (+0,66 %)     JENSEN-GROUP 73.200 € (-0,81 %)     NYXOAH 0.880 € (+3,53 %)     SOLVAY 23.920 € (-3,94 %)     MELEXIS 57.650 € (+0,52 %)     ELIA GROUP 124.300 € (+2,64 %)     VGP 62.900 € (+1,94 %)     ONTEX GROUP 1.696 € (-1,74 %)     CAMPINE 174.000 € (-1,14 %)     AB INBEV 74.360 € (+0,79 %)     ONWARD MEDICAL 2.145 € (-2,28 %)     MONTEA 62.600 € (+1,29 %)     BEKAERT 39.100 € (0,00 %)     ASCENCIO 52.400 € (-0,57 %)     RETAIL ESTATES 61.700 € (0,00 %)     UCB 219.000 € (+6,73 %)     DECEUNINCK 2.390 € (-0,62 %)     CENERGY 21.780 € (-1,80 %)     SOFINA 259.000 € (+0,15 %)     PROXIMUS 5.650 € (-3,75 %)     AEDIFICA 62.850 € (+0,80 %)  
   INTEGRAGEN 0.056 € (+105,88 %)     CREDIT AGRICOLE 15.245 € (-0,36 %)     DSM FIRMENICH AG 107.500 € (-2,05 %)     WOLTERS KLUWER 83.720 € (-0,45 %)     LVMH 386.750 € (-0,83 %)     LAKEFRONT BIOTHER. 27.180 € (+2,72 %)     REXEL 31.720 € (-4,08 %)     WORLDLINE 11.340 € (-3,44 %)     BNP PARIBAS ACT.A 86.950 € (-0,44 %)     BRUNEL INTERNAT 6.880 € (-1,29 %)     UNIBAIL-RODAMCO-WE 88.660 € (+0,77 %)     TECHNIP ENERGIES 30.760 € (-0,19 %)     COMPAGNIE ODET 979.000 € (-1,51 %)     AIR LIQUIDE 172.240 € (-0,67 %)     B.COM.PORTUGUES 1.099 € (-0,68 %)     GTT 201.400 € (-2,89 %)     NANOBIOTIX 21.200 € (+12,47 %)     RENAULT 27.740 € (+1,69 %)     ASML HOLDING 1 455.400 € (-2,71 %)     PERNOD RICARD 66.960 € (-0,74 %)     UMG 16.060 € (-0,40 %)     VIRBAC 345.000 € (+2,37 %)     MERSEN 37.000 € (-4,05 %)     LOUIS HACHETTE 1.761 € (+1,27 %)     TOTALENERGIES 79.940 € (-0,73 %)     VINCI 106.500 € (-0,14 %)     GETLINK SE 19.290 € (+1,21 %)     CALIBRE 0.000 € (+50,00 %)     WERELDHAVE 17.040 € (+0,35 %)     BAM GROEP KON 11.720 € (+1,47 %)     HEIJMANS KON 81.800 € (+0,74 %)     BOUYGUES 40.650 € (-0,49 %)     EDENRED 29.220 € (-2,57 %)     ARKEMA 55.100 € (-1,17 %)     RELX 34.920 € (+0,11 %)     SANOFI 73.580 € (+3,62 %)     KERING 216.400 € (+0,67 %)     SAINT GOBAIN 67.140 € (+1,08 %)     BASTIDE LE CONFORT 18.120 € (+1,12 %)     ERAMET 36.060 € (+2,10 %)     ARGAN 67.600 € (0,00 %)     COVIVIO 43.080 € (-0,23 %)     AKZO NOBEL 58.460 € (-0,14 %)     HERMES INTL 1 339.000 € (+0,15 %)     ADP 111.300 € (+2,20 %)     ESSILORLUXOTTICA 150.500 € (-1,02 %)     LEGRAND 127.300 € (-3,05 %)     BIOMERIEUX 87.200 € (+0,40 %)     BASIC-FIT 31.200 € (+2,77 %)     ALTEN 84.300 € (-1,06 %)     PHARMING GROUP 0.853 € (+3,09 %)     ARCELORMITTAL SA 56.120 € (-0,71 %)     STMICROELECTRONICS 41.005 € (-0,47 %)     CAPGEMINI 123.000 € (-0,12 %)     ASM INTERNATIONAL 739.800 € (-2,68 %)     SPIE 40.560 € (-0,69 %)     UNILEVER 58.350 € (+0,21 %)     SOITEC 123.650 € (-3,74 %)     VIEL ET COMPAGNIE 17.180 € (+0,82 %)     ORANGE 14.290 € (+0,63 %)  
INTERPARFUMS
ITP - FR0004024222 - Euronext Paris
32,440 EUR   17:35
+0,43 %
21/10/2026 07:00

Q3 2026 sales. €265.5m (+4.8%)

Q3 2026 sales €265.5m (+4.8%)

With sales of €265.5m in the third quarter of 2026, up 4.8% at current exchange rates and 4.6% at constant exchange rates compared with the third quarter of 2025, Interparfums regained momentum in an environment that remains turbulent, particularly in the Middle East and Eastern Europe.This strong performance was driven by the growth of major brands, including Coach and Montblanc.

During the first nine months of 2026, consolidated sales reached almost €680m, a modest decline of 2.9% at current exchange rates and 0.7% at constant exchange rates compared with the first nine months of 2025.

Nine-month activity by brand

€mQ3 2025Q3 202626/259 months 20259 months 202626/25
Jimmy Choo73.874.1-178.0179.0+1%
Coach52.565.7+25%158.8175.3+10%
Montblanc54.861.9+13%147.1153.3+4%
Lacoste26.527.9+5%78.769.1-12%
Rochas9.59.5-29.327.0-8%
Lanvin10.58.5-19%30.122.9-24%
Other brands25.917.9-31%78.453.2-32%
Sales253.5265.5+5%700.4679.8- 3%
  • With sales close to €180m, Jimmy Choo fragrances continued to perform well, despite the unfavorable euro/dollar exchange rate*. In the United States, the brand’s main market, growth reached +6%, thanks to the continued success of the I Want Choo and Jimmy Choo Man franchises and bolstered by the launch of several extensions over the past twelve months;
  • Coach fragrances achieved sales of €175m, up 10% since the start of the year.This growth is based on the strength of women’s and men’s historical lines and the success of two new extensions launched during the first quarter;
  • Montblanc fragrances resumed their growth trajectory following a period marked by the absence of any major launches, thanks to the success of the Montblanc Legend Elixir and Montblanc Explorer Infinite lines, launched in the first and third quarters respectively;
  • After the first half of the year was marked by a high basis of comparison and a lack of dynamism in some markets, Lacoste fragrances recorded growth of 5% in the third quarter, driven mainly by the Lacoste Original franchise. This improvement is an encouraging sign ahead of the significant growth expected from 2027 onwards;
  • Sales of Rochas fragrances remained stable following the launch of the Rochas Audace franchise in 2025;
  • Ahead of the launch of new men’s and women’s initiatives over the coming months, Lanvin fragrances is suffering sourcing problems for some components.

Nine-month activity by region

€mQ3 2025Q3 202626/259 months 20259 months 202626/25
Africa1.71.9+14%4.95.3+8%
Asia26.835.3+32%89.496.9+8%
Eastern Europe21.715.1-31%57.043.1-24%
France15.315.1-2%42.642.3-1%
Middle East12.98.7-32%37.825.6-32%
North America107.2115.5+8%271.1276.1+2%
South America21.324.4+14%66.470.9+7%
Western Europe46.549.5+7%131.2119.6-9%
Sales253.5265.5+5%700.4679.8-3%
  • North America, the group’s main market, continued its sustained growth, with local sales for the US subsidiary Interparfums Luxury Brands up by 9%.This success, though offset by an unfavorable currency effect*, was driven mainly by Coach, Jimmy Choo and Montblanc fragrances;
  • South America continued to perform well, thanks in particular to Jimmy Choo and Montblanc fragrances, recording growth of close to 7% over the first nine months of the year;
  • After a mixed performance at the start of the year, Asia saw a return to solid growth, driven by sales of Coach and Jimmy Choo fragrances and a strong performance in China. The region recorded growth of close to 32% in the third quarter and 8% over nine months;
  • The operational difficulties encountered since the start of the year in some Eastern European markets continued, mainly impacting the activity of Lanvin and Lacoste fragrances;
  • Following a lack of momentum during the first half of the year, Western Europe saw an improvement in activity for the third quarter, especially in Germany, the United Kingdom and Spain;
  • In France, the strong performance of Lacoste and Montblanc fragrances made up for a consumer environment that continues to be prudent;
  • Lastly, the Middle East continued to be affected by the consequences of persistent conflicts in the region.

* 1.16 on average over 9 months 2026 compared with 1.12 over 9 months 2025

Upcoming events

Publication of 2027 outlook
November 19, 2026
(before the opening of the Paris stock market)

Publication of 2026 sales
January 27, 2027
(before the opening of the Paris stock market)

Investor Relations and Analysts Contacts

Philippe Santi
Executive Vice President
psanti@interparfums.fr

Nicolas Picaud
Investor Relations Director
npicaud@interparfums.fr

Press contact

Cyril Levy-Pey
Communication Director
clevypey@interparfums.fr

Philippe Benacin, Chairman and Chief Executive Officer, said: “ Our activity regained more favorable momentum over the summer, allowing us to target the top of our sales guidance of around €870m for 2026 as a whole.We nevertheless remain prudent for the fourth quarter, in view of an international context that continues to be complicated, not least in the Middle East and Eastern Europe.We should not forget the strong seasonality of the American market, structurally focused towards the months of November and December. In the end, the very favorable reception from our partners to the 2027 launch plan reinforces our confidence in the group’s growth prospects, which will be outlined on November 19. ”

Paris, October 21, 2026

Interparfums
10 rue de Solférino
75007 Paris
Tel. +33 (0)1 53 77 00 00

This press release is available in French and English on the company’s website interparfums-finance.fr

ISIN : FR0004024222-ITP
Reuters : IPAR.PA
Bloomberg : ITP
Euronext Compartment A
Eligible for Deferred Settlement Service (SRD) - Eligible for PEA

Source : Webdisclosure.com

© 2026 Tous droits réservés
Cotations différées d'au moins 15 minutes (Paris, Amsterdam, Bruxelles, Lisbonne).
Cotations à la clôture (Francfort, New-York, Londres, Zurich).
Flux de cotations : Euronext (Places Euronext et Cours des Devises).
Bourse : technologie Cote Boursière